Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia
Tóm tắt
The World Health Organization Disability Assessment Schedule (WHODAS-2.0) has been adapted and validated in several cultures, but data on performance in the African context are lacking. The aim of the study was to evaluate the validity and psychometric properties of the WHODAS-2.0 among people with severe mental disorders (SMD) and their caregivers in a rural African setting. The content validity of the 36 item WHODAS was assessed using free listing and pile sorting in 36 community members. Cognitive interviewing was conducted with 20 people with SMD and 20 caregivers to assess comprehensibility. Convergent validity and sensitivity to change were evaluated in a facility-based cohort study of new or acutely relapsed cases of people with SMD (n = 150) and their caregivers (n = 150) consecutively recruited from a psychiatric clinic. A repeat assessment was conducted in a sub-sample (n = 84) after 6 weeks. Confirmatory factor analysis was used to evaluate construct validity in people with SMD (n = 250) and their caregivers (n = 250). Internal consistency of the items of the overall scale and each domain ranged from very good (alpha = 0.82) to excellent (alpha = 0.98). Scores on the WHODAS-2.0 correlated highly with a locally developed measure of functioning (r = 0.88) and moderately with clinical symptom severity (r = 0.52). The WHODAS- 2.0 was sensitive to treatment changes (effect size = 0.50). As hypothesized, the six sub-scales loaded highly onto the general disability factor and each item loaded significantly onto their respective domains. The factor loadings of each item in the one factor model of the brief version of WHODAS (12 item) were also high. For both 12- and 36-item scales the goodness of fit indices, were close to, but outside of, recommended ranges. The caregiver data of both the 36 and 12 item versions had similar psychometric properties, but higher mean values and better responsiveness to change. Our study showed that both the 12 and 36 item versions of the WHODAS 2.0 have acceptable validity and psychometric properties and can be used as a cross-cultural measure; however, careful and rigorous adaptation is required for rural African settings.
Tài liệu tham khảo
Mont D. Measuring health and disability. Lancet. 2007;369:1658–63.
Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–32.
Thomas C, Narahari SR, Bose KS, Vivekananda K, Nwe S, West DP, Kwasny M, Kundu RV. Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ. PLoS Negl Trop Dis. 2014;8:e2716.
Bolton P, Tang AM. An alternative approach to cross-cultural function assessment. Soc Psychiatry Psychiatr Epidemiol. 2002;37:537–43.
Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H, et al. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes. 2010;8:51.
Gold LH. DSM-5 and the assessment of functioning: The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). J Am Acad Psychiatry Law. 2014;42:173–81.
Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, Korffe MV, Pullf C. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815–23.
World Health Organization. Towards a common language for functioning, disability and health: ICF. Geneva: World Health Organization; 2002.
Chang K-H, Lin Y-N, Liao H-F, Yen C-F, Escorpizo R, Yen T-H, Liou T-H. Environmental effects on WHODAS 2.0 among patients with stroke with a focus on ICF category e120. Qual Life Res. 2014;23:1823–31.
Andrews G, Kemp A, Sunderland M, Korff MV, Ustun TB. Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS One. 2009;4:e8343.
Silva C, Coleta I, Silva AG, Amaro A, Alvarelhão J, Queirós A, Rocha N. Adaptation and validation of WHODAS 2.0 in patients with musculoskeletal pain. Rev Saude Publica. 2013;47:1–6.
Kirchberger I, Braitmayer K, Coenen M, Oberhauser C, Meisinger C. Feasibility and psychometric properties of the German 12-item WHO Disability Assessment Schedule (WHODAS 2.0) in a population-based sample of patients with myocardial infarction from the MONICA/KORA myocardial infarction registry. Popul Health Metrics. 2014;12:27.
Hu L, Zang Y-L, Li N. The applicability of WHODAS 2.0 in adolescents in China. J Clin Nurs. 2012;21:2438–51.
Downing NR, Kim J-I, Williams JK, Long JD, Mills JA, Paulsen JS. WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease. Eur J Hum Genet. 2014;22:958–63.
Guilera G, Gómez-Benito J, Pino Ó, Rojo E, Vieta E, Cuesta MJ, Purdon SE, Bernardo M, Crespo-Facorro B, Franco M, et al. Disability in bipolar I disorder:The 36-item World Health Organization Disabilit Assessment Schedule2.0. J Affect Disord. 2015;174:353–60.
Guilera G, Gómez-Benito J, Pino O, Rojo JE, Cuesta MJ, Martínez-Arán A, Safont G, Tabarés-Seisdedos R, Vieta E, Bernardo M, et al. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia. Schizophr Res. 2012;138:240–7.
Kebede D, Alem A, Shibre T, Fekadu A, Fekadu D, Kullgren G, et al. The Butajira-Ethiopia study on the incidence, course and outcome of schizophrenia and bipolar disorders. I. Descriptions of study settings, methods and preliminary results. Schizophr Res. 2000;41:78.
Mayston R, Alem A, Habtamu A, Shibre T, Fekadu A, Hanlon C. Participatory planning of a primary care service for people with severe mental disorders in rural Ethiopia. Health Policy Plan. 2015;0:1–10.
Hanlon C, Alem A, Medhin G, Shibre T, Ejigu DA, Negussie H, Dewey M, Wissow L, Prince M, Susser E, et al. Task sharing for the care of severe mental disorders in a low-income country (TaSCS): study protocol for a randomised, controlled, non-inferiority trial. Trials. 2016;17:76.
Carlozzi NE, Kratz AL, Downing NR, Goodnight S, Miner JA, Migliore N, Paulsen JS. Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD). Qual Life Res. 2015;24:1963–71.
Mogga S, Prince M, Alem A, Kebede D, Stewart R, Glozier N, Hotopf M. Outcome ofmajor depression in Ethiopia: population-based study. Br J Psychiatry. 2006;189:241–6.
Senturk V, Hanlon C, Medhin G, Dewey M, Araya M, Alem A, Prince M, Stewart R. Impact of perinatal somatic and common mental disorder symptoms on functioning in Ethiopian women: the P-MaMiE population-based cohort study. J Affect Disod. 2012;136:340–9.
Habtamu K, Alem A, Medhin G, Fekadu A, Prince M, Hanlon C. Development and validation of a contextual measure of functioning for people living with severe mental disorders in rural Africa. BMC Psychiatry. 2016;16:311.
Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.
Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.
Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F, McGree MF, Keefe RSE, McEvoy JP, et al. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry. 2007;164:428–36.
Overall J, Gorham D. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812.
Gray R, Leese M, Bindman J, Becker T, Burti L, David A, Gournay K, Kikkert M, Koeter M, Puschner B, et al. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry. 2006;189:508–14.
Youngmann R, Zilber N, Workneh F, Giel R. Adapting the SRQ for Ethiopian populations: a culturally-sensitive psychiatric screening instrument. Transcult Psychiatry. 2008;45:566–89.
Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53:459–68.
Hair JF, Black WC, Babin BJ, Anderson RE, Tatham RL. Multivariate data analysis. 6th ed. New Jersey: Prentice Hall; 2006.
Furr RM, Bacharach VR. Psychometrics: an introduction. 2nd ed. Los Angeles: SAGE publications; 2007.
Hu L, Bentler PM. Cutoff criterion for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6:1–55.
Chiu T-Y, Yen C-F, Chou C-H, Lin J-D, Hwang A-W, Liao H-F, Chi W-C. Development of traditional Chinese version of World Health Organization Disability Assessment Schedule 2.0 36 – item (WHODAS 2.0) in Taiwan: validity and reliability analyses. Res Dev Disabil. 2014;35:2812–20.
Zhao HP, Liu Y, Li HL, Ma L, Zhang YJ, Wang J. Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: psychometric properties and validation of the Chinese version of the WHODAS 2.0. Qual Life Res. 2013;22:897–906.
Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol. 2004;39:442–7.
Kebede D, Alem A, Shibre T, Negash A, Deyassa N, Beyero T, Medhin G. Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia. Schizophr Res. 2005;78:171–85.
Habtamu K, Alem A, Hanlon C. Conceptualizing and contextualizing functioning in people with severe mental disorders in rural Ethiopia: a qualitative study. BMC Psychiatry. 2015;15:34.
Bellack AS, Green MF, Cook JA, Fenton W, Harvey PD, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, et al. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull. 2007;33:805–22.
Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson TL, Harvey PD. Self-assessment of functional status in schizophrenia. J Psychiatr Res. 2007;41:1012–8.
McKnight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29:243–59.
Sousa RM, Dewey ME, Acosta D, Jotheeswaran AT, Castro-Costa E, Ferri CP, Guerra M, Huang Y, Jacob KS, Pichardo JGR, et al. Measuring disability across cultures - the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries. The 10/66 Dementia Research Group population-based survey. Int J Methods Psychiatr Res. 2010;19:1–17.
Luciano JV, Ayuso-Mateos JL, Fernández A, Serrano-Blanco A, Roca M, Haro JM. Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS II) in Spanish primary care patients with a first major depressive episode. J Affect Disord. 2010;121:52–8.
Schneider M, Baron E, Davies T, Bass J, Lund C. Making assessment locally relevant: measuring functioning for maternal depression in Khayelitsha, Cape Town. Soc Psychiatry Psychiatr Epidemiol. 2015;50:797–806.
World Health Organization. mhGAP: scaling up care for mental, neurological and substance abuse disorders. Geneva: World Health Organization; 2008.